The Hain Celestial Group, Inc.
1.3100-0.04 (-2.96%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · HAIN · USD
Key Stats
Market Cap
118.28MP/E (TTM)
-Basic EPS (TTM)
-5.89Dividend Yield
0%Recent Filings
8-K
Hain's 2025 earnings slump
The Hain Celestial Group reported fiscal 2025 results on September 15, 2025, with net sales dropping 10% to $1.56B amid 7% organic declines from volume weakness in snacks and meal prep, while gross margins slipped to 21.4%. Heavy $496M impairment charges fueled a $531M net loss, yet adjusted EBITDA held at $114M and debt fell to $705M. Management is slashing costs and streamlining operations for cash flow gains. Leverage covenant now caps at 5.50x.
10-K
FY2025 results
Hain Celestial's FY2025 net sales fell 10.2% y/y to $1.56B, with organic sales down 6.5% amid volume/mix weakness and divestitures, though Q4 showed modest sequential stabilization in North America snacks via pricing actions. Gross margins compressed to 21.4% from 21.9%, pressured by inflation and trade spend, yet productivity gains lifted Adjusted EBITDA to $113.8M despite $428.9M goodwill impairments tied to market cap declines and strategic reviews. North America drove the downturn with 15.8% sales drop, while International held steadier at -1.4%; Q4 momentum hinged on UK soups offsetting beverage softness. Liquidity stood firm with $54.4M cash and $246.7M revolver availability, no buybacks executed under the $173.5M program. No formal FY2026 guidance issued amid ongoing portfolio review. Intense competition risks eroding quarterly gains if consumer shifts persist.
10-Q
Q3 FY2025 results
Hain Celestial's Q3 FY2025 net sales fell 11.0% y/y to $390.4M, with organic sales down 5.3% (derived) on softer North America volumes in snacks and personal care, while International held steady via meal prep gains; gross margin slipped 0.4 points to 21.7% amid pricing pressures, yet productivity offset some hits. Operating loss widened to $121.1M from $27.9M, driven by $110.3M goodwill impairment in U.S./Canada units, but Adjusted EBITDA (reconciled in filing) dipped 23.2% to $33.6M. Diluted EPS of -$1.49 aligns with 90,247k shares and net loss, no anti-dilution flagged. Cash stood at $44.4M with $352.2M revolver availability under covenants; sold ParmCrisps in Aug 2024 for $12M cash, recognizing $3.9M loss, and personal care assets now held for sale after $23.1M writedown. Free cash flow turned positive at $5.7M YTD (derived). Baby food litigation lingers, with multidistrict proceedings advancing on arsenic claims.
8-K
CEO Transition and Q3 Miss
The Hain Celestial Group announced on May 7, 2025, that CEO Wendy Davidson departed effective May 6, with board member Alison Lewis stepping in as interim CEO the next day, backed by a $100,000 monthly salary and $900,000 RSU grant. Amid Q3 results showing net sales down 11% to $390 million and a $135 million net loss driven by $133 million impairments, the board launched a strategic portfolio review with Goldman Sachs to boost shareholder value. North America sales plunged 17%, yet international grew organically 0.5%. Leadership shakeup signals urgency.
10-Q
Q2 FY2025 results
Hain Celestial's Q2 FY2025 net sales fell 9.4% y/y to $411.5M, with organic sales down 6.8% (derived) on softer North America demand in snacks and personal care, while international held steadier amid soup gains; gross margin edged up to 22.7% from productivity offsets. Operating loss widened to $91.9M from a $91.3M goodwill impairment in the U.S. unit and $18.0M in asset write-downs, versus a slim $0.8M loss last year—net loss hit $104.0M or $1.15/share, versus $13.5M or $0.15/share, with the gap mainly from impairments exceeding operating shortfalls by over 20%. YTD sales dropped 8.3% to $806.1M, operating cash flow slowed to $20.1M (FCF $8.0M, derived), and debt eased to $728.6M with $334.2M revolver availability and covenant compliance. The ParmCrisps sale closed August 2024 for $12.0M cash, deconsolidating $7.3M goodwill. Ongoing baby food litigation poses regulatory risks.
CAG
ConAgra Brands, Inc.
17.38-0.70
HCWC
Healthy Choice Wellness Corp.
0.64-0.01
HLF
Herbalife Ltd.
8.02-0.09
HRL
Hormel Foods Corporation
21.49-2.16
KHC
The Kraft Heinz Company
24.38-1.14
LWAY
Lifeway Foods, Inc.
24.16-1.17
NATR
Nature's Sunshine Products, Inc
13.42-0.43
OTLY
Oatly Group AB
15.08-0.54
SMPL
The Simply Good Foods Company
19.69-0.09
USNA
USANA Health Sciences, Inc.
19.61-0.72